Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 22688768)

1.

Mousepox, a small animal model of smallpox.

Esteban D, Parker S, Schriewer J, Hartzler H, Buller RM.

Methods Mol Biol. 2012;890:177-98. doi: 10.1007/978-1-61779-876-4_11.

PMID:
22688768
2.

Obligatory requirement for antibody in recovery from a primary poxvirus infection.

Chaudhri G, Panchanathan V, Bluethmann H, Karupiah G.

J Virol. 2006 Jul;80(13):6339-44. Erratum in: J Virol. 2006 Sep;80(17):8844.

3.

Homing studies on distribution of ectromelia (mousepox) virus-specific T cells adoptively transferred into syngeneic H-2d mice: paradigm of lymphocyte migration.

Gieryńska M, Toka FN, Cespedes IS, Schollenberger A, Malicka E, Popis A, Niemiałtowski MG.

Viral Immunol. 2000;13(1):107-23.

PMID:
10733173
4.

Ectromelia virus: the causative agent of mousepox.

Esteban DJ, Buller RM.

J Gen Virol. 2005 Oct;86(Pt 10):2645-59. Review.

PMID:
16186218
6.

Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.

Chaudhri G, Panchanathan V, Buller RM, van den Eertwegh AJ, Claassen E, Zhou J, de Chazal R, Laman JD, Karupiah G.

Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9057-62. Epub 2004 Jun 7.

7.

Induction of natural killer cell responses by ectromelia virus controls infection.

Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RM.

J Virol. 2007 Apr;81(8):4070-9. Epub 2007 Feb 7.

8.

Studying NK cell responses to ectromelia virus infections in mice.

Fang M, Sigal L.

Methods Mol Biol. 2010;612:411-28. doi: 10.1007/978-1-60761-362-6_28.

PMID:
20033657
9.
10.

N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.

Gratz MS, Suezer Y, Kremer M, Volz A, Majzoub M, Hanschmann KM, Kalinke U, Schwantes A, Sutter G.

J Virol. 2011 Apr;85(7):3557-69. doi: 10.1128/JVI.01191-10. Epub 2011 Jan 26.

11.

Genetic resistance to smallpox: lessons from mousepox.

Karupiah G, Panchanathan V, Sakala IG, Chaudhri G.

Novartis Found Symp. 2007;281:129-36; discussion 136-40, 208-9. Review.

PMID:
17534070
12.

Mousepox outbreak in a laboratory mouse colony.

Dick EJ Jr, Kittell CL, Meyer H, Farrar PL, Ropp SL, Esposito JJ, Buller RM, Neubauer H, Kang YH, McKee AE.

Lab Anim Sci. 1996 Dec;46(6):602-11.

PMID:
9001171
13.

The inflammatory and immune response to mousepox (infectious ectromelia) virus.

Niemiałtowski MG, Spohr de Faundez I, Gieryńska M, Malicka E, Toka FN, Schollenberger A, Popis A.

Acta Virol. 1994 Oct;38(5):299-307. Review.

PMID:
7726007
14.
15.

The ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responses.

Melo-Silva CR, Tscharke DC, Lobigs M, Koskinen A, Wong YC, Buller RM, Müllbacher A, Regner M.

J Virol. 2011 Nov;85(21):11170-82. doi: 10.1128/JVI.00256-11. Epub 2011 Aug 17.

16.

Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox.

Parker S, Chen NG, Foster S, Hartzler H, Hembrador E, Hruby D, Jordan R, Lanier R, Painter G, Painter W, Sagartz JE, Schriewer J, Mark Buller R.

Antiviral Res. 2012 Apr;94(1):44-53. doi: 10.1016/j.antiviral.2012.02.005. Epub 2012 Feb 18.

17.
18.

A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.

Israely T, Paran N, Lustig S, Erez N, Politi B, Shafferman A, Melamed S.

Virol J. 2012 Jun 18;9:119. doi: 10.1186/1743-422X-9-119.

19.

The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.

Xu RH, Cohen M, Tang Y, Lazear E, Whitbeck JC, Eisenberg RJ, Cohen GH, Sigal LJ.

J Exp Med. 2008 Apr 14;205(4):981-92. doi: 10.1084/jem.20071854. Epub 2008 Apr 7.

20.

Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.

Parker S, Crump R, Foster S, Hartzler H, Hembrador E, Lanier ER, Painter G, Schriewer J, Trost LC, Buller RM.

Antiviral Res. 2014 Nov;111:42-52. doi: 10.1016/j.antiviral.2014.08.003. Epub 2014 Aug 13.

PMID:
25128688
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk